Form 4: Telesis Bio Inc. Director Michael R. Hodges Acquires Shares and Options

Director Michael R. Hodges acquired shares and options in Telesis Bio Inc. on July 24, 2024, through restricted stock units (RSUs) and stock options.

Summary

• On July 24, 2024, Michael R. Hodges, a director of Telesis Bio Inc., acquired 8,390 shares of common stock through restricted stock units (RSUs).
• Hodges also acquired options to purchase 5,268 shares of common stock at an exercise price of $4.10.
• The RSUs vest over time, with 3,512 RSUs vesting in equal annual installments from the grant date and 4,878 RSUs vesting fully on January 1, 2025, contingent upon continued service.
• The stock options vest in equal monthly installments following the grant date, also contingent upon continued service.
• Following these transactions, Hodges directly owns 8,390 shares of Telesis Bio Inc. common stock and options to purchase 5,268 shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of insider transactions. The director's acquisition could be seen as a positive signal, but it's not a major event.

Positives

• The acquisition of shares and options by a director signals confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in the beneficial ownership of Telesis Bio Inc. securities by a director.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates

Keywords

Telesis Bio Inc., Michael R. Hodges, Form 4, Director, Stock Options, RSUs, Beneficial Ownership, TBIO